.png)
Hi community!
I am excited to say that since the beginning of this year we have published many of the client SDKs for InterSystems IRIS, InterSystems IRIS for Health and Health Connect to the corresponding external repositories (Maven, NuGet, npm and PyPI). This provides many benefits to you such as:
- You can access the latest releases for a client SDK as soon as they get published, independent of the InterSystems IRIS release cadence
- You can integrate the SDKs as a dependency with the native package manager tool within your ecosystem and manage dependencies in an industry-standard way
- End users can access the SDKs directly e.g., when they are looking for direct access to the database layer through a SQL tool such as DBeaver
- You can publish projects with dependencies on InterSystems client SDKs without including them directly in your project
Here is a list of client SDKs we have published so far, as well as the corresponding version number of the latest release and where to find them:
Java
| JDBC | 3.10.5 | https://mvnrepository.com/artifact/com.intersystems/intersystems-jdbc |
| Document API | 1.0.3 | https://mvnrepository.com/artifact/com.intersystems/intersystems-document |
.NET
| ADO | 2.6.0 | https://www.nuget.org/packages/InterSystems.Data.IRISClient/ |
| Bindings | 2.5.2 | https://www.nuget.org/packages/InterSystems.Data.Bindings/ |
| XEP | 2.4.0 | https://www.nuget.org/packages/InterSystems.Data.XEP/ |
| Entity Framework Core | 1.0.0 | https://www.nuget.org/packages/InterSystems.EntityFrameworkCore.Iris/ |
| Document API | 1.1.0 |
Node.js
Python
| Python SDK | 5.3.0 | https://pypi.org/project/intersystems-irispython/ |
Going forward client SDKs will be published to external repositories as soon as a new version is available. The external repositories will also become the major distribution channel for client SDKs.
Usage of the client SDKs is subject of the Terms of Use as outlined here: https://www.intersystems.com/IERTU/
If you haven't used the external repositories yet, I encourage you to give them a try. As always, we are looking forward to your feedback!
